Singapore Retail Pharmacy Market
Singapore Retail Pharmacy Market Expands at 7.8% CAGR to Reach USD 5.8 Billion by 2030
Published | 14 October 2024
Singapore Retail Pharmacy Market is thriving due to growing health and wellness awareness among the rapidly aging population, an increasing demand for over the counter (OTC) medications, expanding e-pharmacy services, and the government’s healthcare initiatives.
BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated Singapore Retail Pharmacy Market size by value at USD 3.45 billion in 2023. During the forecast period between 2024 and 2030, BlueWeave expects Singapore Retail Pharmacy Market size to expand at a CAGR of 7.80% reaching a value of USD 5.79 billion by 2030. Major driving factors for Singapore Retail Pharmacy Market include the growing elderly population, increasing prevalence of chronic diseases, and rising healthcare awareness. Expanding access to over the counter (OTC) medications, health supplements, and wellness products has boosted market growth. Additionally, the shift towards self-care and preventive health, supported by government healthcare initiatives, fuels demand. The convenience of e-commerce and digital health services further drives the market, with pharmacies offering teleconsultation and online delivery services to meet evolving consumer preferences.
Sample Request @ https://www.blueweaveconsulting.com/report/singapore-retail-pharmacy-market/report-sample
Opportunity –Increasing Availability of Generic Drugs
The growing availability of generic drugs is expected to be a key driver for Singapore Retail Pharmacy Market. As healthcare costs rise, generic alternatives provide more affordable options for consumers, especially in treating chronic conditions. Regulatory support from the Health Sciences Authority (HSA) for generic approvals ensures quicker market entry, increasing their accessibility. Pharmacies benefit from wider product ranges and competitive pricing, while consumers appreciate the cost savings without compromising on safety or efficacy, driving the overall market.
Impact of Escalating Geopolitical Tensions on Singapore Retail Pharmacy Market
Escalating geopolitical tensions could affect Singapore Retail Pharmacy Market by disrupting global supply chains, leading to potential shortages of medications and healthcare products. Increased import costs and currency fluctuations may drive up prices, affecting affordability for consumers. Additionally, regulatory changes or trade restrictions could limit the availability of certain pharmaceuticals. However, demand for essential health products may rise during times of uncertainty, offering growth opportunities for local manufacturers and pharmacies focused on stocking crucial supplies.
Drug Retail Segment Holds Largest Share of Singapore Market
The drug retail segment accounts for the largest share of Singapore Retail Pharmacy Market by form type. The segment includes the sale of prescription and over the counter (OTC) medications, which form the backbone of retail pharmacy operations in the country. The rising demand for chronic disease management, the aging population, and accessibility to pharmaceuticals contribute to its dominance. Drug retail remains essential as pharmacies cater to consumers seeking medications for health conditions, both acute and long-term, making it the leading revenue generator in the retail pharmacy landscape.
Competitive Landscape
Singapore Retail Pharmacy Market is fiercely competitive, with numerous companies vying for a larger market share. Major companies in the market include Guardian Health and Beauty, Watsons, Unity Pharmacy, Pharmaplus, Wellcome, Happy Pharmacy, Cuckoo Pharmacy, Redmart, and iHerb. These companies use various strategies, including increasing investments in their R&D activities, mergers and acquisitions, joint ventures, collaborations, licensing agreements, and new product and service releases to further strengthen their position in Singapore Retail Pharmacy Market.
The in-depth analysis of the report provides information about growth potential, upcoming trends, and statistics of Singapore Retail Pharmacy Market. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in Singapore Retail Pharmacy Market and industry insights to help decision-makers make sound strategic decisions. Further, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.
Scope of the Report
Attributes |
Details |
Years Considered |
Historical Data – 2019–2023 |
Base Year – 2023 |
|
Estimated Year – 2024 |
|
Forecast Period – 2024–2030 |
|
Facts Covered |
Revenue in USD Billion |
Market Coverage |
Singapore |
Product/Service Segmentation |
Type, Drug Type, End User |
Key Players |
Guardian Health and Beauty, Watsons, Unity Pharmacy, Pharmaplus, Wellcome, Happy Pharmacy, Cuckoo Pharmacy, Redmart, iHerb |
About Us
BlueWeave Consulting provides comprehensive Market Intelligence (MI) Solutions to businesses regarding various products and services online and offline. We offer all-inclusive market research reports by analyzing both qualitative and quantitative data to boost the performance of your business solutions. BlueWeave has built its reputation by delivering quality inputs and nourishing long-lasting relationships with its clients. We are one of the promising digital MI solutions companies providing agile assistance to make your business endeavors successful.
Contact Us:
BlueWeave Consulting & Research Pvt Ltd
+1 866 658 6826 | +1 425 320 4776 | +44 1865 60 0662
Get Help
Related Report
Publish Date: October 2024
Rising chronic diseases, increasing healthcare expenditures, aging population, a spurring demand for OTC medications, and the convenience of online pharmacy are expected to drive Singapore Retail Pharmacy Market during the forecast period between 2024 and 2030.
Relevant Press Releases
- United States Syringes Market Size to Grow at 5.6% CAGR to Touch Healthy Value of USD 3.75 Billion by 2030
- United States In-Vitro Diagnostics (IVD) Market Size to Surpass USD 49 Billion by 2030
- Global Aseptic Pharma Processing Equipment Market Projected to Touch Market Worth USD 12.9 Billion: Growing at a CAGR of 7.2% in the Forecast Period
- Asia Pacific Pharmacy Automation Market to Grow at a CAGR of 9.2% during Forecast Period
- Global Eyewear Market to Remain Prolific—Projected to Reach worth USD 177.1 Billion in 2027